Distributor inventory | Tablet

Type 2 diabetes mellitus (as an add-on to diet and exercise), especially for control of post-meal (postprandial) blood glucose; may be used alone or with other antidiabetic medicines as prescribed.

Voglibose is an alpha-glucosidase inhibitor that slows the breakdown and absorption of carbohydrates in the intestine. This reduces the rise in blood glucose after meals and helps improve overall glycaemic control.

Oral tablet. Typically taken just before meals or with the first bite of food, as prescribed by the doctor. Do not skip meals after taking; follow diet and exercise advice and monitor blood glucose regularly.

Flatulence, abdominal pain, diarrhea, bloating, nausea

Use with caution in patients with inflammatory bowel disease, intestinal obstruction, chronic intestinal disorders, or severe digestive problems. Not recommended in diabetic ketoacidosis. Monitor liver enzymes if advised; rare liver function abnormalities can occur. If hypoglycaemia occurs when used with insulin/sulfonylureas, treat with glucose (dextrose) rather than sucrose/table sugar. Consult doctor in elderly and in renal/hepatic impairment.

Insulin, sulfonylureas (e.g., glimepiride, gliclazide) may increase risk of hypoglycaemia; other antidiabetics; intestinal adsorbents/digestive enzyme preparations may reduce effect; corticosteroids and thyroid hormones may affect glycaemic control; alcohol may increase risk of hypoglycaemia with combination therapy.

Store below 25°C in a cool, dry place. Protect from moisture and direct light. Keep out of reach of children.

Voglibose 0.2 mg tablet (generic), Volix 0.2 Tablet, Vobose 0.2 Tablet, Voglimac 0.2 Tablet, Vogli 0.2 Tablet